Bladder Cancer Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Bladder Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Mar 04, 2019

---

• Interest of next-generation sequencing in BCG-treated high-risk bladder cancer.  
  Jungels C et al. Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie 2018 May 28(6) 344-350
• Clinical and Genomic Considerations for Variant Histology in Bladder Cancer.  
  Matulay Justin T et al. Current oncology reports 2019 Feb 21(3) 23
• Ability of a urine gene expression classifier to reduce the number of follow-up cystoscopies in bladder cancer patients.  
  Montalbo Ruth et al. Translational research : the journal of laboratory and clinical medicine 2019 Feb
• Validation of a DNA Methylation-Mutation Urine Assay to Select Patients with Hematuria for Cystoscopy.  
  van Kessel Kim E M et al. The Journal of urology 2017 197(3 Pt 1) 590-595
• Advances in HER2-Targeted Therapy: Novel Agents and Opportunities Beyond Breast and Gastric Cancer.  
  Meric-Bernstam Funda et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2018 Nov
• Diagnostic value of combined IQGAP3/BMP4 and IQGAP3/FAM107A expression ratios in urinary cell-free DNA for discriminating bladder cancer from hematuria.  
  Xu Yanjie et al. Urologic oncology 2018 Nov
• Genomic classification and risk stratification of bladder cancer.  
  Fantini Damiano et al. World journal of urology 2018 Nov
• Circulating miRNA Panels for Specific and Early Detection in Bladder Cancer.  
  Usuba Wataru et al. Cancer science 2018 Nov
• Novel biomarkers in bladder cancer.  
  Cheng Michael L et al. Urologic oncology 2018 36(3) 115-119
• Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behaviour of bladder cancer.  
  Leão Ricardo et al. International journal of cancer 2018 Oct
• Development and Validation of a 28-gene Hypoxia-related Prognostic Signature for Localized Prostate Cancer.  
  Yang Lingjian et al. EBioMedicine 2018 May 31182-189
• Genomics of drug sensitivity in bladder cancer: an integrated resource for pharmacogenomic analysis in bladder cancer.  
  Ansari Adnan Ahmad et al. BMC medical genomics 2018 Oct 11(1) 88
• Clinical performance and utility of a NNMT-based urine test for bladder cancer.  
  Pozzi Valentina et al. The International journal of biological markers 2018 Jan 33(1) 94-101
• Precision medicine and bladder cancer heterogeneity.  
  Ma Guofeng et al. Bulletin du cancer 2018 Sep
• Prognostic Signature of Alternative Splicing Events in Bladder Urothelial Carcinoma Based on Spliceseq Data from 317 Cases.  
  He Rong-Quan et al. Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology 2018 48(3) 1355-1368